MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Archives & Legacy
*Developments: Celgene (Archives 2011-2015)
Parents
Archives & Legacy
Developments: Celgene
Children
2011: Acceleron Pharma raises $30M Celgene strategic financing (2011)
2012: Celgene’s multiple myeloma drug setback in Europe gets mixed response
2012: Foundation Medicine and Sanofi Form Cancer Discovery Pact
2014: Celgene Gets FDA Nod For Oral Arthritis Drug
2014: Epizyme Heads Back to Wall Street, Plans $140M Raise
2014: NanoString (NSTG), Celgene (CELG) Strike $45M Companion Diagnostic Pact More...
2015: 4 Reasons To Keep An Eye On Top Biotech Celgene CELG REGN AMGN BIIB
2015: Celgene backing Soon-Shiong's cancer biotech IPO, now dubbed NantKwest
2015: Celgene taps Cypher Genomics to spot biomarkers in data sets
2015: Juno-Celgene Deal Has Street Cautiously Optimistic CELG JUNO BLUE
2015: Who's most at risk if the U.S. cracks down on prices? Gilead, Celgene top the list
5. Celgene - $745M (€544M) 2010 R&D